Bayer has filed for approval in the US for elinzanetant as a non-hormonal treatment for menopausal symptoms such as hot flushes, with a rival therapy from Astellas in its sights. The FDA submission is ...
Given the serious financial and reputational risks of incidents that grind business to a halt, organizations need to prioritize a prevention-first cybersecurity strategy Under lock and key: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback